在沃尔特里德陆军医疗中心，对来自战伤患者的鲍曼不动杆菌-醋酸钙不动杆菌的氨基糖苷类抗生素阿贝卡星的体外活性研究。
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
机构信息
Infectious Disease Service, Walter Reed Army Medical Center, 6900 Georgia Ave., Washington, DC 20307, USA.
出版信息
Antimicrob Agents Chemother. 2010 Jul;54(7):3015-7. doi: 10.1128/AAC.01173-09. Epub 2010 Apr 19.
Abstract
We determined the in vitro MIC of arbekacin against 200 Acinetobacter isolates recovered from wounded soldiers. The median MIC was 2 microg/ml (range, 0.5 to > 64 microg/ml). A total of 97.5% of the isolates had arbekacin MICs of < 8 microg/ml and 86.5% had MICs of < or = 4 microg/ml. There was no association between the arbekacin MIC and susceptibility to 16 other antibiotics or the specimen source (P = 0.7239). Synergy testing suggested an enhanced effect of arbekacin-carbapenem combinations.
摘要
我们测定了阿贝卡星对 200 株从受伤士兵中分离的不动杆菌的体外 MIC。中位 MIC 为 2μg/ml（范围 0.5 至>64μg/ml）。共有 97.5%的分离株阿贝卡星 MIC 值<8μg/ml，86.5%的 MIC 值<或=4μg/ml。阿贝卡星 MIC 值与对 16 种其他抗生素的敏感性或标本来源之间无相关性（P=0.7239）。协同试验提示阿贝卡星-碳青霉烯类联合用药有增效作用。
相似文献
1
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.在沃尔特里德陆军医疗中心，对来自战伤患者的鲍曼不动杆菌-醋酸钙不动杆菌的氨基糖苷类抗生素阿贝卡星的体外活性研究。
Antimicrob Agents Chemother. 2010 Jul;54(7):3015-7. doi: 10.1128/AAC.01173-09. Epub 2010 Apr 19.
2
Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.优化碳青霉烯类抗生素与氨基糖苷类抗生素联合使用以对抗耐碳青霉烯鲍曼不动杆菌的新方法。
Antimicrob Agents Chemother. 2015 Apr;59(4):2286-98. doi: 10.1128/AAC.04379-14. Epub 2015 Feb 2.
3
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.阿普拉霉素对多重耐药、碳青霉烯类和氨基糖苷类耐药肠杆菌科和鲍曼不动杆菌的体外活性。
J Antimicrob Chemother. 2019 Apr 1;74(4):944-952. doi: 10.1093/jac/dky546.
4
[In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].舒巴坦与亚胺培南、美罗培南和头孢哌酮联合对耐碳青霉烯类鲍曼不动杆菌分离株的体外协同活性
Mikrobiyol Bul. 2014 Apr;48(2):311-5. doi: 10.5578/mb.7104.
5
In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals.
Braz J Infect Dis. 2001 Jun;5(3):130-5. doi: 10.1590/s1413-86702001000300005. Epub 2003 Feb 19.
6
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia.阿贝卡星对从肺炎住院患者中分离出的当代临床细菌的活性。
Antimicrob Agents Chemother. 2015;59(6):3263-70. doi: 10.1128/AAC.04839-14. Epub 2015 Mar 23.
7
8
In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.替加环素对台湾地区鲍曼不动杆菌临床分离株的体外活性。
Int J Antimicrob Agents. 2008 Nov;32 Suppl 3:S188-91. doi: 10.1016/S0924-8579(08)70026-8.
9
In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.在体外研究氨基糖苷类药物对引起台湾医疗相关性血流感染的鲍曼不动杆菌复合体和其他非发酵革兰阴性杆菌临床分离株的活性。
J Microbiol Immunol Infect. 2016 Dec;49(6):918-923. doi: 10.1016/j.jmii.2015.07.010. Epub 2015 Aug 14.
10
In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.黏菌素与利福平及碳青霉烯类药物对耐黏菌素鲍曼不动杆菌临床分离株的体外抗菌协同作用
Diagn Microbiol Infect Dis. 2016 Oct;86(2):184-9. doi: 10.1016/j.diagmicrobio.2016.07.017. Epub 2016 Jul 19.
引用本文的文献
1
Clinical Usefulness of Arbekacin.阿贝卡星的临床应用价值
Infect Chemother. 2016 Mar;48(1):1-11. doi: 10.3947/ic.2016.48.1.1. Epub 2016 Mar 31.
2
Mutational and acquired carbapenem resistance mechanisms in multidrug resistant Pseudomonas aeruginosa clinical isolates from Recife, Brazil.巴西累西腓多药耐药铜绿假单胞菌临床分离株中的突变及获得性碳青霉烯耐药机制
Mem Inst Oswaldo Cruz. 2015 Dec;110(8):1003-9. doi: 10.1590/0074-02760150233. Epub 2015 Dec 15.
3
Detecting 16S rRNA Methyltransferases in Enterobacteriaceae by Use of Arbekacin.使用阿贝卡星检测肠杆菌科中的16S rRNA甲基转移酶
J Clin Microbiol. 2016 Jan;54(1):208-11. doi: 10.1128/JCM.02642-15. Epub 2015 Nov 4.
4
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia.阿贝卡星对从肺炎住院患者中分离出的当代临床细菌的活性。
Antimicrob Agents Chemother. 2015;59(6):3263-70. doi: 10.1128/AAC.04839-14. Epub 2015 Mar 23.
5
Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens.阿贝卡星：一种用于治疗耐甲氧西林金黄色葡萄球菌和多重耐药革兰氏阴性病原体所致感染的新型药物。
Clin Pharmacol. 2014 Sep 26;6:139-48. doi: 10.2147/CPAA.S44377. eCollection 2014.
6
Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study.印度南部阿贝卡星、头孢米诺、磷霉素、比阿培南及其他抗生素对革兰氏阴性临床分离株的最低抑菌浓度分布测定：一项前瞻性研究。
PLoS One. 2014 Jul 28;9(7):e103253. doi: 10.1371/journal.pone.0103253. eCollection 2014.
7
Detection of New Delhi metallo-β-lactamase (encoded by blaNDM-1) in Acinetobacter schindleri during routine surveillance.在常规监测中检测到宋内志贺菌中的新德里金属β-内酰胺酶（由 blaNDM-1 编码）。
J Clin Microbiol. 2013 Jun;51(6):1942-4. doi: 10.1128/JCM.00281-13. Epub 2013 Apr 3.
本文引用的文献
1
Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center.在一家三级医疗中心，静脉注射黏菌素（多黏菌素甲磺酸钠）治疗相关的肾毒性。
Clin Infect Dis. 2009 Jun 15;48(12):1724-8. doi: 10.1086/599225.
2
Emergence of multidrug resistance in bacteria and impact on antibiotic expenditure at a major army medical center caring for soldiers wounded in Iraq and Afghanistan.一家主要军队医疗中心照顾在伊拉克和阿富汗受伤士兵时细菌多重耐药性的出现及其对抗生素支出的影响。
Infect Control Hosp Epidemiol. 2008 Jul;29(7):661-3. doi: 10.1086/588702.
3
Combat wounds in operation Iraqi Freedom and operation Enduring Freedom.伊拉克自由行动和持久自由行动中的战斗创伤。
J Trauma. 2008 Feb;64(2):295-9. doi: 10.1097/TA.0b013e318163b875.
4
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.抗菌治疗的药代动力学-药效学：不再只是针对小鼠了。
Clin Infect Dis. 2007 Jan 1;44(1):79-86. doi: 10.1086/510079. Epub 2006 Nov 27.
5
Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus.阿贝卡星治疗耐甲氧西林金黄色葡萄球菌感染患者的药代动力学-药效学关系
Antimicrob Agents Chemother. 2006 Nov;50(11):3763-9. doi: 10.1128/AAC.00480-05.
6
Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.基于阿贝卡星的联合用药对万古霉素异质性中介金黄色葡萄球菌的协同作用。
J Korean Med Sci. 2006 Apr;21(2):188-92. doi: 10.3346/jkms.2006.21.2.188.
7
In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals.
Braz J Infect Dis. 2001 Jun;5(3):130-5. doi: 10.1590/s1413-86702001000300005. Epub 2003 Feb 19.
8
Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.氨苄西林联合阿贝卡星治疗由耐高水平庆大霉素的粪肠球菌菌株引起的实验性兔心内膜炎的疗效。
Antimicrob Agents Chemother. 2000 Sep;44(9):2545-6. doi: 10.1128/AAC.44.9.2545-2546.2000.
9
Aminoglycosides: activity and resistance.氨基糖苷类：活性与耐药性。
Antimicrob Agents Chemother. 1999 Apr;43(4):727-37. doi: 10.1128/AAC.43.4.727.
10
The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups.
Clin Infect Dis. 1997 Jan;24 Suppl 1:S46-62. doi: 10.1093/clinids/24.supplement_1.s46.
Zotero 插件